MONTVALE, N.J., Aug. 2 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals
Corp. (Nasdaq: MEMY) announced today that it will report its second quarter
financial results on Thursday, August 9, 2007, before the U.S. financial
markets open. Management will provide a Company update and discuss the second
quarter results during a conference call on Thursday, August 9, 2007, at 9:00
a.m. EDT.
Investors and other interested parties may access the call as follows:
Date: Thursday, August 9, 2007
Time: 9:00 a.m. EDT
Telephone (U.S.): 866-713-8565
Telephone (international): 617-597-5324
Participant Passcode: 77253492
Webcast: http://www.memorypharma.com under the
"Investors" section
An audio replay of the conference call will be available from 11:00 a.m.
EDT on Thursday, August 9, 2007, until Thursday, August 16, 2007. To access
the replay, please dial 888-286-8010 (U.S.) or 617-801-6888 (international)
and enter pass code number 58601384. An audio replay of the conference call
will also be available under the "Investors" section of the Company's website
during the same period.
About the Company
Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on
developing innovative drugs for the treatment of debilitating CNS disorders
such as Alzheimer's disease, schizophrenia, depression and bipolar disorder.
For additional information, please visit our website at
http://www.memorypharma.com.
SOURCE Memory Pharmaceuticals Corp.
-0- 08/02/2007
/CONTACT: Jzaneen Lalani, General Counsel, +1-201-802-7249, for Memory
Pharmaceuticals Corp.; or Laura Perry of Stern Investor Relations, Inc.,
+1-212-362-1200/
/Web site: http://www.memorypharma.com /
(MEMY)
CO: Memory Pharmaceuticals Corp.
ST: New Jersey
IN: HEA BIO MTC FIN
SU: CCA
SF-AP
-- NYTH001 --
1703 08/02/2007 10:30 EDT http://www.prnewswire.com
